On March 10, a small but mighty group of Endocrine Society members came to Washington D.C., to meet with their congressional delegations. Despite a number of other priorities requiring the attention of Congress, the federal appropriations process for FY 2021 must move forward and this is the time to influence decisions about funding. We used...
Author: Mark Newman
Bones of Contention: The Unintended Effects of Cancer Therapy
Therapies that can extend the life of cancer patients often have a negative impact on the skeleton, especially in those being treated for hormone-sensitive cancers. Evidence shows improvements in bone health when bisphosphonates and denosumab are administered. Patients diagnosed with cancer are living longer, with some unanticipated ramifications. According to Facts & Figures 2018, published...
Virtual event to incorporate content from meeting cancelled amid COVID-19 pandemic Today, the Endocrine Society announced that it will host its largest-ever online meeting in June to ensure endocrine researchers and clinicians continue to have access to the latest scientific information, despite the COVID-19 pandemic. ENDO Online 2020 will feature a mixture of on-demand and live programming for both clinical and research audiences. The... The Guardian News environment reporter Emily Holden received the Endocrine Society’s annual Award for Excellence in Science and Medical Journalism, the Society announced today. Holden is being honored for her coverage of our everyday exposure to harmful chemicals found in plastics, cosmetics and food. The winning article, “Is modern life poisoning me? I took the tests to find out,” was published in The Guardian News in May 2019. This article is part of Toxic America,...
In transgender men, what are the consequences of gender-affirming hormonal therapy on fertility? Led by Molly B. Moravek, MD, MPH, a team of researchers from the Center for Reproductive Medicine, in Ann Arbor, Mich., set out to answer that question as well as summarize the current literature on the topic of transgender men desiring reproduction...
Endocrine Society Announces 2020 Early Investigators Award Winners
The Endocrine Society has selected five recipients for its 2020 Early Investigators Awards. The Early Investigators Awards were established to assist in the development of early-career investigators and to provide greater recognition of their accomplishments in endocrine-related research. The Endocrine Society’s 2020 Early Investigators Award winners are: Mehmet Furkan Burak, MD, of Brigham and Women’s Hospital in Boston, Mass. His research...
Insulin Sensitivity Improves with Testosterone Therapy in Men with Type 2 Diabetes and Hypogonadism
About a third of men with type 2 diabetes (T2D) also have hypogonadotropic hypogonadism (HH). This comorbidity makes that subgroup more insulin resistant, with increased adiposity and less lean mass, according to research published recently in The Journal of Clinical Endocrinology & Metabolism. A team led by Paresh Dandona, BSc, MB, BS, DPhil, FRCP, of...
As men age, testosterone levels decrease, but current guidelines recommend testing in symptomatic men only, and there has been a lack of consensus about what point that decrease becomes a deficiency. Healthy aging men have been presumed to have higher serum testosterone levels than their counterparts with obesity, smoking history, or associated comorbidities, but large-scale...
